Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00387049 · ClinicalTrials.gov registry record · NA
Anxiety Sensitivity Program for Smoking Cessation
A NA study, sponsored by University of Vermont.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00387049 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 80 participants.
The verdict
NCT00387049, a NA study, has completed, sponsored by University of Vermont.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and test a smoking cessation intervention for persons who are specifically sensitive to anxiety and anxiety-related bodily sensations.
Interventions
- BEHAVIORAL Anxiety Sensitivity Program for Smoking Cessation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2005-01 |
| Est. Completion | 2010-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00387049
The ClinicalTrials.gov registry entry for NCT00387049 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anxiety Sensitivity Program for Smoking Cessation is the first listed.
NCT00387049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00387049 about?
NCT00387049 is a clinical study titled "Anxiety Sensitivity Program for Smoking Cessation". The purpose of this study is to develop and test a smoking cessation intervention for persons who are specifically sensitive to anxiety and anxiety-related bodily sensations.
What is the current status of trial NCT00387049?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2005-01. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00387049?
The interventions under investigation include: Anxiety Sensitivity Program for Smoking Cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00387049?
This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.